CA1059991A - CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP - Google Patents

CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP

Info

Publication number
CA1059991A
CA1059991A CA216,571A CA216571A CA1059991A CA 1059991 A CA1059991 A CA 1059991A CA 216571 A CA216571 A CA 216571A CA 1059991 A CA1059991 A CA 1059991A
Authority
CA
Canada
Prior art keywords
group
compound
formula
lower alkyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA216,571A
Other languages
English (en)
French (fr)
Other versions
CA216571S (en
Inventor
Gordon I. Gregory
Martin C. Cook
Janice Bradshaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Operations UK Ltd
Original Assignee
Glaxo Operations UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Operations UK Ltd filed Critical Glaxo Operations UK Ltd
Priority to CA314,938A priority Critical patent/CA1067068A/en
Priority to CA314,937A priority patent/CA1067067A/en
Application granted granted Critical
Publication of CA1059991A publication Critical patent/CA1059991A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA216,571A 1973-12-21 1974-12-20 CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP Expired CA1059991A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA314,938A CA1067068A (en) 1973-12-21 1978-10-30 3-CARBAMOYLOXYMETHYL-7-(.alpha.-(1-CARBOXYCYCLOBUT-1-OXYIMINO)-.alpha.-(FUR-2-YL) ACETAMIDO) CEPH-3-EM-4-CARBOXYLIC ACID
CA314,937A CA1067067A (en) 1973-12-21 1978-10-30 3-CARBAMOYLOXYMETHYL-7-(.alpha.-CARBOXYMETHOXYIMINO-.alpha.(FUR-2-YL)ACETAMIDO)CEPH-3-EM-4-CARBOXYLIC ACID

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB59517/73A GB1496757A (en) 1973-12-21 1973-12-21 Cephalosporin derivatives

Publications (1)

Publication Number Publication Date
CA1059991A true CA1059991A (en) 1979-08-07

Family

ID=10483908

Family Applications (1)

Application Number Title Priority Date Filing Date
CA216,571A Expired CA1059991A (en) 1973-12-21 1974-12-20 CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP

Country Status (8)

Country Link
JP (1) JPS5655392A (ja)
BE (1) BE823651A (ja)
CA (1) CA1059991A (ja)
CH (1) CH626370A5 (ja)
FR (1) FR2355849A1 (ja)
GB (1) GB1496757A (ja)
PH (1) PH11646A (ja)
ZA (1) ZA748146B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO760358L (ja) * 1975-02-04 1976-08-05 Fujisawa Pharmaceutical Co
AR229883A1 (es) 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
CA1130280A (en) * 1978-10-27 1982-08-24 Cynthia H. O'callaghan Cephalosporin compounds
IL58717A (en) * 1978-11-15 1983-05-15 Glaxo Group Ltd Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
US5262410A (en) * 1986-12-23 1993-11-16 Ici Pharma 3-heterocyclic thiomethyl cephalosporins
EP0272827A3 (en) * 1986-12-23 1990-02-07 ZENECA Pharma S.A. 3-heterocyclicthiomethyl cephalosphorins
US20040166434A1 (en) 2003-02-21 2004-08-26 Dammel Ralph R. Photoresist composition for deep ultraviolet lithography
WO2009073620A2 (en) 2007-11-30 2009-06-11 Newlink Genetics Ido inhibitors

Also Published As

Publication number Publication date
BE823651A (fr) 1975-06-20
PH11646A (en) 1978-05-08
JPS5655392A (en) 1981-05-15
FR2355849A1 (fr) 1978-01-20
ZA748146B (en) 1976-01-28
GB1496757A (en) 1978-01-05
CH626370A5 (en) 1981-11-13
FR2355849B1 (ja) 1980-10-17

Similar Documents

Publication Publication Date Title
US3971778A (en) Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
US4767852A (en) New process for producing cephalosporin antibiotics, and novel intermediates for use in such process and their production
FI67555C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbart (6 7r)-7-((z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxi imno)-acetamido)-3-(1-pyridiniummetyl)-cef-3-em-4-karboxyla t
US4168309A (en) Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
CA1055016A (en) 7.alpha.-LOWER ALKOXY-7.beta.-(2-ARYL-2-HYDROXYIMINOACETAMIDO) CEPH-3-EM-4-CARBOXYLIC ACIDS
US4103084A (en) 7-(Carboxy substituted α-etherified oximino arylacetamido) cephalosporins having a 3-vinyl or substituted vinyl group
CA1059991A (en) CEPHALOSPORINS HAVING A 7-(CARBOXY SUBSTITUTED .alpha.-ETHERIFIED OXIMINOARYLACETAMIDO) GROUP
IE42144B1 (en) Improvements in or relating to antibiotics
US4074047A (en) 7 2-(Aminocarbonylalkoxyimino)acetamido! derivatives of cephalosporin
JPS625916B2 (ja)
US4165430A (en) Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
US4369312A (en) Method of producing oxo-containing azetidinone compounds
US4138555A (en) (6R,7R)-7-[2-aryl-2-(etherified oximino)acetamido]-3-carbamoyloxymethylceph-3-em-4-carboxylic acid 1-oxides
US4091209A (en) 7β-[2-Etherified oximino-2-(phenyl or naphthylacetamido)]cephalosporins having a 2-haloalkylcarbamoyloxymethyl group at the 3-position
US4385177A (en) Cephalosporins having a carbamoylalkoxyiminoarylacetamido group at 7-position
US4144392A (en) Cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyimino-arylacetamido group and at position-3 the residue of a sulphur nucleophile
US4060686A (en) Cephalosporins having a 7-(carboxy substituted α-etherified oximinoarylacetamido) group
CA1074297A (en) Cephalosporins
US4162360A (en) 3-Carbamoyloxymethyl-7-substituted oximino acetamido cephalosporanic acid derivatives
IE42318B1 (en) Improvements in or relating to cephalosporins
US4122259A (en) 7β-[2-Aryl-2-(etherified oximino)acetamido]-3-N-substituted carbamoyloxymethylceph-3-em-4-carboxylic acids
IE47032B1 (en) Compounds with terminal aminocarboxylic acid grouping
US4560683A (en) Cephalosporin antibiotics
CA1073901A (en) Cephalosporins
US4200746A (en) Cephalosporins